Journal Article

Paronychia in Association with Indinavir Treatment

Amy E. Colson, Paul E. Sax, Marla J. Keller, Barbara K. Turk, Parker T. Pettus, Richard Platt and Peter W. Choo

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 32, issue 1, pages 140-143
Published in print January 2001 | ISSN: 1058-4838
Published online January 2001 | e-ISSN: 1537-6591 | DOI: http://dx.doi.org/10.1086/317546
Paronychia in Association with Indinavir Treatment

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

To assess a possible association between antiretroviral treatment and paronychia, we conducted a retrospective cohort study of 288 human immunodeficiency virus-positive protease inhibitor recipients. Indinavir treatment—adjusted for age, sex, CD4 count, diabetes status and other antiretroviral drug exposures—was significantly associated with paronychia of the great toe (hazard ratio 4.7; 95% confidence interval 1.6–13.9).

Journal Article.  2170 words.  Illustrated.

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.